In a Phase 2 trial, patients with early Parkinsons disease taking an older GLP-1 diabetes drug called lixisenatide experienced no worsening of motor symptoms over a year, in contrast to patients on placebo who did, according to the study, published Wednesday in the New England Journal of Medicine
Journal Reference : Amalie Dyrelund Broks, Mads Brner, Bolette Hartmann, Knud Josefsen, Jens Juul Holst, Tue Wenzel Kragstrup
Philip M
Hydration: Water keeps blood flowing and nutrients moving to healing tissues
This antioxidant function connects MOTS-c to the suppression of oxidative stress, one of the canonical drivers of biological aging
However, starting at low doses and coordinating closely with your bariatric surgeon minimizes any adverse effects